Das Biswadeep, Sarkar Chayna
Department of Pharmacology, Kasturba Medical College, Manipal, Karnataka-576 119, India.
Life Sci. 2005 Jul 29;77(11):1226-48. doi: 10.1016/j.lfs.2004.12.042.
The relative contributions of cardiomyocyte sarcolemmal ATP-sensitive K(+) (K(ATP)) and mitochondrial K(ATP) channels in the cardioprotection and antiarrhythmic activity induced by K(ATP) channel openers remain obscure, though the mitochondrial K(ATP) channels have been proposed to be involved as a subcellular mediator in cardioprotection afforded by ischemic preconditioning. In the present study, we sought to investigate the effects of administration of ATP-sensitive K(+) channel (K(ATP)) openers (nicorandil and minoxidil), a specific mitochondrial K(ATP) channel blocker (5-hydroxydecanoate (5-HD)) and a specific sarcolemmal K(ATP) channel blocker (HMR 1883; (1-[5-[2-(5-chloro-o-anisamido)ethyl]-2-methoxyphenyl]sulfonyl-3-methylthiourea) prior to coronary occlusion as well as prior to post-ischemic reperfusion on survival rate, ischemia-induced and reperfusion-induced arrhythmias and myocardial infarct size in anesthetized albino rabbits. The thorax was opened in the left 4th intercostal space and after pericardiotomy the heart was exposed. In Group I (n=88), occlusion of the left main coronary artery and hence, myocardial ischemia-induced arrhythmias was achieved by tightening a previously placed loose silk ligature for 30 min. In Group II (n=206), arrhythmias were induced by reperfusion following a 20-min ligation of the left main coronary artery. Both in Group I and Group II, intravenous (i.v.) administration of nicorandil (0.47 mg/kg), minoxidil (0.5 mg/kg), HMR 1883 (3 mg/kg)/nicorandil and HMR 1883 (3 mg/kg)/minoxidil before coronary artery occlusion increased survival rate (86%, 75%, 75% and 86% vs. 55% in the control subgroup in Group I; 75%, 67%, 67% and 75% vs. 46% in the control subgroup in Group II), significantly decreased the incidence and severity of life-threatening arrhythmias. In Group II, i.v. administration of nicorandil and minoxidil before coronary artery occlusion significantly decreased myocardial infarct size. However, i.v. administration of nicorandil or minoxidil before reperfusion did neither increase survival rate nor confer any antiarrhythmic or cardioprotective effects. The antiarrhythmic and cardioprotective effects of both nicorandil and minoxidil were abolished by pretreating the rabbits with 5-HD (5 mg/kg, i.v. bolus), a selective mitochondrial K(ATP) channel blocker but not by HMR 1883 (3 mg/kg). In the present study, higher levels of malondialdehyde (MDA) and lower levels of reduced glutathione (GSH) and superoxide dismutase (SOD) in necrotic zone of myocardium in all the 16 subgroups in Group II suggest little anti-free radical property of nicorandil and minoxidil. We conclude that intervention by intravenous administration of nicorandil and minoxidil (through the selective activation of mitochondrial K(ATP) channels) increased survival rate and exhibited antiarrhythmic and cardioprotective effects during coronary occlusion and reperfusion in anesthetized rabbits when administered prior to coronary occlusion. The cardiomyocyte mitochondrial K(ATP) channel may be a pharmacologically modulable target of cardioprotection and antiarrhythmic activity.
心肌细胞肌膜ATP敏感性钾通道(KATP)和线粒体KATP通道在KATP通道开放剂诱导的心脏保护和抗心律失常活性中的相对作用仍不清楚,尽管线粒体KATP通道已被认为作为一种亚细胞介质参与缺血预处理提供的心脏保护。在本研究中,我们试图研究在冠状动脉闭塞前以及缺血后再灌注前给予ATP敏感性钾通道(KATP)开放剂(尼可地尔和米诺地尔)、一种特异性线粒体KATP通道阻滞剂(5-羟基癸酸(5-HD))和一种特异性肌膜KATP通道阻滞剂(HMR 1883;1-[5-[2-(5-氯-邻茴香酰胺基)乙基]-2-甲氧基苯基]磺酰基-3-甲基硫脲)对麻醉的白化兔的存活率、缺血诱导和再灌注诱导的心律失常以及心肌梗死面积的影响。在左第4肋间空间打开胸腔,心包切开术后暴露心脏。在I组(n = 88)中,通过收紧先前放置的宽松丝线结扎30分钟来实现左主冠状动脉闭塞,从而诱导心肌缺血性心律失常。在II组(n = 206)中,通过左主冠状动脉结扎20分钟后再灌注诱导心律失常。在I组和II组中,在冠状动脉闭塞前静脉注射(i.v.)尼可地尔(0.47 mg/kg)、米诺地尔(0.5 mg/kg)、HMR 1883(3 mg/kg)/尼可地尔和HMR 1883(3 mg/kg)/米诺地尔可提高存活率(I组中分别为86%、75%、75%和86%,而对照组亚组为55%;II组中分别为75%、67%、67%和75%,而对照组亚组为46%),显著降低危及生命的心律失常的发生率和严重程度。在II组中,冠状动脉闭塞前静脉注射尼可地尔和米诺地尔可显著减小心肌梗死面积。然而,再灌注前静脉注射尼可地尔或米诺地尔既不能提高存活率,也没有任何抗心律失常或心脏保护作用。尼可地尔和米诺地尔的抗心律失常和心脏保护作用通过用5-HD(5 mg/kg,静脉推注)预处理兔子而被消除,5-HD是一种选择性线粒体KATP通道阻滞剂,但HMR 1883(3 mg/kg)不能消除。在本研究中,II组所有16个亚组中心肌坏死区丙二醛(MDA)水平较高,还原型谷胱甘肽(GSH)和超氧化物歧化酶(SOD)水平较低,提示尼可地尔和米诺地尔几乎没有抗自由基特性。我们得出结论,静脉注射尼可地尔和米诺地尔(通过选择性激活线粒体KATP通道)进行干预可提高存活率,并在冠状动脉闭塞前给药时在麻醉兔的冠状动脉闭塞和再灌注期间表现出抗心律失常和心脏保护作用。心肌细胞线粒体KATP通道可能是心脏保护和抗心律失常活性的药理学可调节靶点。